Background
Introduction study. Written informed consent was obtained from each of the subjects following a complete description of the study. The institutional ethics committee of the First Affiliated Hospital at Xinjiang Medical University approved this study.
Biochemical analyses
Nucleic acid was extracted from the blood samples using the Genomic DNA Mini Kit (TIAN-GEN; Beijing, China). The DNA concentration was measured by the ultramicro nucleic acid ultraviolet tester (NANODROP 1000, Wilmington, USA). Plasma levels of biochemical factors (including triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL)) were detected by biochemical laboratory (Beckman; Brea, CA, USA). DNA methylation levels of each CpG sites were tested by pyrosequencing technology. Sodium bisulphite (EZ DNA Methylation-Gold Kit; ZYMO RESEARCH, Orange County, California, USA) was used to convert all unmethylated cytosines to uracils, and meanwhile the methylated cytosines unchanged. Polymerase chain reaction (PCR) (Zymo Taq PreMix, ZYMO RESEARCH, Orange County, California, USA) was used to augment target DNA sequences. The primers were all designed by PyroMark Assay Design software. The sequences were 5'-TTGGGTTTTA GAGTGGGAGAAAAGT-3' (forward primer), 5'-Biotin-AAACCCTCAAATTCATTCTCTT TACCTACC-3' (reverse primer), and was 5'-AGTGAGAGTAGGTGT-3' (sequencing primer). All the oligomers were synthesized by the Sangon Biotechnology company (Shanghai, China).
Statistical Program for Social Sciences (SPSS) software 16.0 (SPSS, Inc., Chicago, IL, USA) was used in this study and a p value < 0.05 was considered to be significant. Nonparametric testing was used to compare differences in the each CpG sites of continuous variables between the MCI cases and controls. Spearman rank correlation test was used to analyze the associations between KLOTH methylation and metabolic characteristics of MCI subjects.
Results
A total of five CpGs on the KLOTHO promoter were assessed to explore their associations with the risk of MCI (Fig 1) . Significant correlation was found among the methylation levels of the five CpGs (r > 0.524, p < 0.001). As shown in Table 1 and Fig 2, significantly elevated KLOTHO promoter methylation was found in MCI cases than controls in Xinjiang Han Chinese population (CpG1: p = 3.77E-06; CpG2: p = 1.91E-07; CpG3: p = 5.83E-07; CpG4: p = 2.23E-05; CpG5: p = 3.03E-06) but not in Uygur Chinese population. Similar results in the female and male Xinjiang Han Chinese (male: CpG1: p = 0.001; CpG2: p = 2.36E-04; CpG3: p = 0.003; CpG4: p = 0.007; CpG5: p = 0.002, female: CpG1: p = 0.001; CpG2: p = 3.23E-04; CpG3: p = 1.89E-05; CpG4: p = 0.001; CpG5: p = 4.184E-04, Table 2 ).
Since there were significant differences in the age between Uygur and Han samples (MCI cases: p = 6.78E-09; controls: p = 3.22E-09; Table 3 ), thus the population differences of various parameters were adjusted by age. According to the Table 3 Among the 5 phenotypes, significantly higher TC and lower HDL-C levels were found in the Uygur MCI patients than the Uygur controls (TC: p = 0.030; HDL-C: p = 0.010, Fig 4) . Lower levels of HDL-C were found in the Uygur MCI females than the Uygur female controls (p = 0.024, Fig 4) . In the Xinjiang Han Chinese, significantly higher levels of TC and LDL-C were found in the male MCI patients compared to the male controls (TC: p = 0.045, LDL-C: p = 0.005, Fig 4) . After adjusted by age, significantly higher levels of TC, LDL-C, and HDL-C were found in Han MCI patients than Uygur MCI patients (TC: adjusted p = 0.042; LDL-C: adjusted p = 0.011; HDL-C: adjusted p = 0.011, Fig 4) . Significantly lower TG and higher TC and LDL-C levels were found in Han controls than Uygur controls (TG: adjusted p = 0.043; TC: adjusted p = 4.63E-04; LDL-C: adjusted p = 0.008, Fig 4) . Besides, significantly higher levels of LDL-C were found in Han patients than Uygur patients (adjusted p = 0.049, Fig 4) .
As shown in the Table 4 , statistically higher levels of CpG sites were found in Han MCI patients than Uygur MCI patients in the male and female subgroups (male: CpG1: adjusted p = 0.009; CpG2: adjusted p = 0.047; CpG3: adjusted p = 0.009; CpG5: adjusted p = 0.034, Table 4 ; female: CpG1: adjusted p = 0.012; CpG4: adjusted p = 0.017; CpG5: adjusted p = 0.006, Table 4 ). In the male subgroup, the levels of TC and LDL-C were all significantly higher in Han patients compared to Uygur patients (TC: adjusted p = 0.023; LDL-C: adjusted Fig 4) . Significantly higher TC levels were also found in the male Han controls compared to the male Uygur controls (adjusted p = 0.049, Fig 4) . In the females, significantly higher levels of HDL-C were found in the Han MCI patients than the Uygur MCI patients (adjusted Fig 4) .
Discussion
In the current study, we investigated the association between KLOTHO promoter methylation and MCI in two Xinjiang populations. In the Xinjiang Han, significant results were found in the overall analysis and the gender-based subgroup analyses, although no positive results existed in the Uygur population. Significantly higher level of KLOTHO promoter methylation was found in Han patients compared to Uygur patients. In addition, population differences were also found in multiple clinical phenotypes including the levels of TG, TC, HDL-C and LDL-C. Different dietary cultures in two populations might explain the population differences of the above phenotypes. KOLOTHO is a longevity gene and has been considered to be involved in MCI which is an age-related disease. KOLOTHO mainly expressed in brain and kidney, secreting into CSF and serum, respectively [25] . KLOTHO as a related factor to oxidative damage has the ability to protect neurons in brain [26] . KLOTHO was considered as an aging suppressor gene [27] , and over expression of KLOTHO significantly extended the life span of mice [28, 29] .Meanwhile, we found a higher methylation level in KLOTHO promoter in the MCI patients of Xinjiang Han population than matched controls, and the same results were also observed in the subgroup stratified by gender. No difference was found in Uygur population. DNA methylation alteration of promoter was often found to influence gene expression [30] . In addition, hypermethylation of KLOTHO was shown to low expression in hepatocellular carcinoma tissues [31] . Repressions of KLOTHO migth have an adverse effect for MCI patients according to a previous study [27] . Hence, we hypothesized that hypermethylation of KLOTHO promoter might play a role in the development of MCI of Xingjian Han population via the pathway of down regulation of KLOTHO expression. Population difference could change gene activity as described previously [32] . Populations are complicated in Xinjiang Province. Uygur population and Han population belong to Caucasian and Mongolian, respectively [33] . Previous study had investigated significant association between IL-4, IFN-gamma promoter methylation and allergic rhinitis patients of Uygur and Han Chinese in Xinjiang [34] . Significantly higher DNA methylation levels of microRNA-375 promoter were found in Han T2D patients than Kazak T2D patients in Xinjiang [35] . In this study, significantly higher level of KLOTHO promoter methylation was discovered in Han MCI patients than Uygur patients, suggesting a population specific mode of KLOTHO methylation in the susceptibility of MCI.
Dyslipidemia is associated with both the occurrence and progression of MCI. HDL-C and TC were belong to vascular risk factors and could increase the risk of MCI and the risk of conversion from MCI to AD [36, 37] . A correlation between HDL-C and dementia was also revealed in the elderly [38] . A cross-sectional study about cognitive impairment suggested that TC and LDL-C were independent risk factors for MCI [39] . An interdisciplinary longitudinal study showed that higher TC levels were associated with an increased risk for cognitive disorders [40] . Higher TC and lower HDL-C levels were found in Chinese T2D patients with MCI compared to simple T2D patients [41] . Consistent with the previous findings, our study showed a significantly higher TC level in MCI compared to controls in the Uygur population.
Population differences were also found in four phenotypes including TG, TC, HDL-C and LDL-C. Higher levels of TC and LDL-C were found in Han population than Uygur population in both MCI and control subgroup. However, elevation of HDL-C level was only found in the Han MCI patients than Uygur MCI patients. In addition, significantly lower levels of TG were found in Han patients and controls than Uygur patients and controls. These phenotypes are shown to be influenced by many factors including genetic factors, eating habit, and lifestyle [42, 43] . The population differences in both the genetic and the environmental factors might explain the differences of above phenotypes in two populations.
Ethnic difference has been observed in the diagnosis, clinical manifestation, disease management, prevalence, and cause of MCI. Race difference was found in the memory performance even after adjusting by the status of education, depression, gender, and memory complaints [44] . As the measurement of cognitive functioning, Hachinski ischemic scale scores were shown to differ by ethnicity [45] . African American MCI patients were found to have faster rate of cognitive decline compared with non-African American ones [46] . Ethnic disparities were also observed in the management of MCI patients [47] . Caucasian MCI patients underwent significant more neuropsychologic testing; while African-Americans had more depression screening tests and were less likely to be prescribed with acetylcholinesterase inhibitors [47] . The prevalence of dementia has been reported to be higher among African Americans and Caribbean Hispanics, lower among Japanese Americans, and similar among Native Americans and Mexican Americans compared with non-Hispanic whites [48] . English usage in Australia was shown to be related to to lower prevalence of MCI and higher rates of reversion from MCI to normal [49] . In the United States, more African American and Hispanic MCI patients were attributable to diabetes than non-Hispanic white MCI patients [50] . Racial disparities in financial capacity were found to exist among patients with amnestic MCI [51] . Predictive risk factors for MCI in non-Hispanic cohorts were not associated with MCI in Mexican Americans [52] , who were more likely to be possessed the ApoE ε4 allele less frequently [52] . In addition, ApoE ε4 allele was protective for MCI only in Han Chinese but not in Hui Chinese [53] .
In summary, our study identified the contribution of KLOTHO promoter methylation to MCI in Xinjiang Han population. The lack of significant results in the Xinjiang Uygur population might be due to the differences in genetics and environment. Further investigation on the population difference was needed in the future.
